Reuters reported Monday that Pakistani health authorities completed a clinical trial of Chinese traditional medicine herbs to successfully treat COVID-19.
The trials were conducted at the International Center for Chemical and Biological Science (ICCBS). And many of the same herbs that are being used to treat COVID were tested in the trial.
Pakistan is entering its fifth wave of the pandemic. And are now being hit by the Omicron variant.
On Monday Pakistan reported 4,340 COVID-19 cases. This is the highest recorded in a 24-hour period since November 2021. The largest city, Karachi, reported that the percentage of tests coming back positive sets at 39.39%. This is the highest positive rate ever recorded in Pakistan.
The National Command Operation Centre (NCOC) tweeted out “In the last seven days, COVID cases in Pakistan have increased by 170% while deaths have also increased by 62%.”
The Chinese herbal medicine called Jinhua Qinggan Granules (JHQG). It is manufactured by Juxiechang (Beijing) pharmaceutical Co Ltd and is in wide distribution in China as a treatment of COVID-19.
